Contact dermatitis due to imidazole antimycotics

Guidetti, Maria Silvia; Vincenzi, Colombina; Guerra, Liliana; Tosti, Antonella

doi:10.1111/j.1600-0536.1995.tb00495.x

Cited by 14 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Publications on allergic contact dermatitis caused by tioconazole became common following its introduction, in the years 1989 to 1996, and many were related to exposure to a medicated nail solution (Table S2). Interestingly, to our knowledge, no cases have been reported since then in the English‐language literature.…”

Section: Discussionmentioning

confidence: 92%

Is tioconazole contact dermatitis still a concern? Bringing allergic contact dermatitis caused by topical tioconazole back into the spotlight

et al. 2018

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 92%

Is tioconazole contact dermatitis still a concern? Bringing allergic contact dermatitis caused by topical tioconazole back into the spotlight

et al. 2018

View full text Add to dashboard Cite

“…Caused by disperse blue‐coloured synthetic underwear, it had been misdiagnosed as tinea corporis. In most reported cases (7), in fact, sensitivity to antimycotics was caused by preparations prescribed for non‐fungal diseases.…”

Section: Discussionmentioning

confidence: 99%

Allergic contact dermatitis to naftifine

Corazza

Lauriola

2005

Contact Dermatitis

View full text Add to dashboard Cite

show abstract

“…Allergic contact dermatitis can also occur with topical medications ( 52 , 53 ), such as topical antibiotics ( 54–56 ), antiacne drugs ( 57 ), anesthetics ( 58 , 59 ), antihistamines ( 60 , 61 ), testosterone and estrogen from the transdermal therapeutic system ( 52 ), antimycotics ( 62–64 ), sunscreens ( 65–67 ), NSAIDs ( 68 , 69 ) corticosteroids (CS) ( 52 , 70 ).…”

Section: Allergensmentioning

confidence: 99%

Advancing the understanding of allergic contact dermatitis: from pathophysiology to novel therapeutic approaches

et al. 2023

View full text Add to dashboard Cite

Allergic contact dermatitis (ACD) is a common inflammatory skin disease that, especially when the condition becomes chronic, has a high impact on the quality of life and represents a significant disease burden. ACD represents a type IV delayed-type hypersensitivity reaction that is triggered by contact with an allergen in previously sensitized individuals through the activation of allergen-specific T cells. In the acute phase, it is characterized by eczematous dermatitis, which presents with erythema, edema, vesicles, scaling, and intense itch. Non-eczematous clinical forms are also described (lichenoid, bullous, and lymphomatosis). Lichenification is the most common clinical picture in the chronic phase if the culprit allergen is not found or eliminated. ACD can be associated with both occupational and non-occupational exposure to allergens, representing approximately 90% of occupational skin disorders along with irritant contact dermatitis. Patch testing with suspected allergens is required for a diagnosis. Metals, especially nickel, fragrance mix, isothiazolinones, and para-phenylenediamine, are the most commonly positive allergens in patients patch tested for suspected ACD. The treatment goal is to avoid contact with the culprit agent and use topical and/or systemic corticosteroid therapy.

show abstract

Contact dermatitis due to imidazole antimycotics

Cited by 14 publications

References 5 publications

Is tioconazole contact dermatitis still a concern? Bringing allergic contact dermatitis caused by topical tioconazole back into the spotlight

Is tioconazole contact dermatitis still a concern? Bringing allergic contact dermatitis caused by topical tioconazole back into the spotlight

Allergic contact dermatitis to naftifine

Advancing the understanding of allergic contact dermatitis: from pathophysiology to novel therapeutic approaches

Contact Info

Product

Resources

About